Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

October 15, 2025; Volume 22,Issue 10
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Abudureheman, Abudukadierjiang

    1. Open Access
      Current progress in neoantigen-based dendritic cell vaccines for solid tumors
      Yuting Li, Abudukadierjiang Abudureheman and Jianming Xu
      Cancer Biology & Medicine October 2025, 22 (10) 1143-1157; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0267
  2. Al-kofahi, Taqwa

    1. Open Access
      Revisiting strategies to target ABC transporter-mediated drug resistance in CNS cancer
      Haneen Amawi, Alaa M. Hammad, F. Scott Hall, Noor Hussein, Aseel O. Rataan, Abeer Mrayyan, Taqwa Al-kofahi, Ali Hmedat, Charles R. Ashby and Amit K. Tiwari
      Cancer Biology & Medicine October 2025, 22 (10) 1158-1180; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0060
  3. Amawi, Haneen

    1. Open Access
      Revisiting strategies to target ABC transporter-mediated drug resistance in CNS cancer
      Haneen Amawi, Alaa M. Hammad, F. Scott Hall, Noor Hussein, Aseel O. Rataan, Abeer Mrayyan, Taqwa Al-kofahi, Ali Hmedat, Charles R. Ashby and Amit K. Tiwari
      Cancer Biology & Medicine October 2025, 22 (10) 1158-1180; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0060
  4. Ashby , Charles R.

    1. Open Access
      Revisiting strategies to target ABC transporter-mediated drug resistance in CNS cancer
      Haneen Amawi, Alaa M. Hammad, F. Scott Hall, Noor Hussein, Aseel O. Rataan, Abeer Mrayyan, Taqwa Al-kofahi, Ali Hmedat, Charles R. Ashby and Amit K. Tiwari
      Cancer Biology & Medicine October 2025, 22 (10) 1158-1180; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0060
  5. Cao, Mengxuan

    1. Open Access
      Radiomic model for preoperative prediction of mismatch repair deficiency in gastric cancer: a multicenter study integrating tumor sub-region radiomics and transcriptomics
      Siwei Pan, Enze Li, Guoliang Zheng, Yi You, Yanqiang Zhang, Mengxuan Cao, Ruolan Zhang, Qing Yang, Yizhou Wei, Weiwei Zhu, Ke Shen, Chencui Huang, Jingxu Xu, Lijing Wang, Zaisheng Ye, Zhiyuan Xu and Can Hu
      Cancer Biology & Medicine October 2025, 22 (10) 1210-1217; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0254
  6. Chang, Le

    1. Open Access
      Targeting mitochondrial dysfunction to intervene in liver cancer
      Maomao Li, Siyao Liang, Le Chang, Bingyan Lu, Jiahua Cheng, Tian Yang, Ying Wu, Yuhong Lyu, Xiaochan He and Changwu Yue
      Cancer Biology & Medicine October 2025, 22 (10) 1181-1209; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0180
  7. Chen, Xingyun

    1. Open Access
      Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma
      Xiaoqing Ma, Chenyang Meng, Xuejing Shi, Zhaoyu Zhang, Qiuli Li, Hongwei Wang, Yuexiang Liang, Song Gao, Xiuchao Wang, Chuntao Gao, Jian Wang, Weidong Ma, Yukuan Feng, Shuo Li, Xingyun Chen, Wei Li, Shangheng Shi, Tianxing Zhou, Jun Yu and Jihui Hao
      Cancer Biology & Medicine October 2025, 22 (10) 1255-1266; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0181
  8. Cheng, Jiahua

    1. Open Access
      Targeting mitochondrial dysfunction to intervene in liver cancer
      Maomao Li, Siyao Liang, Le Chang, Bingyan Lu, Jiahua Cheng, Tian Yang, Ying Wu, Yuhong Lyu, Xiaochan He and Changwu Yue
      Cancer Biology & Medicine October 2025, 22 (10) 1181-1209; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0180
  9. Dai, Xiaoqiu

    1. Open Access
      Cancer mortality trends in China from 2013–2021 and projections to 2030
      Xin Liang, Yifei Yao, Xiang Li, Ting Gao and Xiaoqiu Dai
      Cancer Biology & Medicine October 2025, 22 (10) 1223-1239; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0158
  10. Feng, Yukuan

    1. Open Access
      Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma
      Xiaoqing Ma, Chenyang Meng, Xuejing Shi, Zhaoyu Zhang, Qiuli Li, Hongwei Wang, Yuexiang Liang, Song Gao, Xiuchao Wang, Chuntao Gao, Jian Wang, Weidong Ma, Yukuan Feng, Shuo Li, Xingyun Chen, Wei Li, Shangheng Shi, Tianxing Zhou, Jun Yu and Jihui Hao
      Cancer Biology & Medicine October 2025, 22 (10) 1255-1266; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0181
« Previous (Pages : 1 2 3 4 5 6 ... 10) Next »
Back to top
Previous

In this issue

Cancer Biology & Medicine: 22 (10)
Cancer Biology & Medicine
Vol. 22, Issue 10
15 Oct 2025
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire